- Home
- IART vs BBNX Comparison
IART vs BBNX Comparison
Compare IART & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IART | BBNX |
|---|---|---|
| Founded | 1989 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1995 | 2025 |
Fundamental Metrics
Financial Performance| Metric | IART | BBNX |
|---|---|---|
| Price | $13.60 | $20.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $15.00 | ★ $28.92 |
| AVG Volume (30 Days) | 774.3K | ★ 884.4K |
| Earning Date | 02-24-2026 | 10-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,642,966,000.00 | $88,570,000.00 |
| Revenue This Year | $3.26 | $52.13 |
| Revenue Next Year | $2.71 | $36.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 4.99 | ★ 67.01 |
| 52 Week Low | $10.87 | $8.89 |
| 52 Week High | $27.13 | $32.71 |
Technical Indicators
Market Signals| Indicator | IART | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 28.30 |
| Support Level | $11.86 | $28.36 |
| Resistance Level | $14.12 | $32.58 |
| Average True Range (ATR) | 0.54 | 1.88 |
| MACD | 0.12 | -0.67 |
| Stochastic Oscillator | 81.85 | 10.27 |
Price Performance
Historical ComparisonAbout IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.